Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Neonatal sepsis remains one of the most important cause of mortality and morbidities in China. This study will establish a prospective registral cohort of all infants with culture-proven neonatal sepsis in Chinese NICUs participating in the Chinese Neonatal Network (CHNN). The microbiology, antimicrobial resistance patterns and neonatal outcomes will be described in detail for this cohort.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antibiotic Therapy for Early Onset Neonatal Sepsis

NCT03932123

Early Onset Neonatal Sepsis

RECRUITING

Neonatal Antimicrobial Resistance and Outcome

NCT05743816

Neonatal Infection

UNKNOWN

Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants

NCT00189384

Bacterial Infection Sepsis Infant, Newborn

UNKNOWN PHASE3

Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis

NCT03453177

Neonatal SEPSIS

COMPLETED PHASE2

Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment

NCT00487019

Early Onset Neonatal Sepsis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All infants with culture-proven sepsis in NICUs of CHNN will be enrolled in the study. Detailed data on microbiology, resistance pattern, neonatal mortality and morbidities will be collected and described. Risk factors for multi-resistant bacteria infections and for sepsis-related mortality will be identified.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Antimicrobial Resistance Neonatal Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Infants with bacteria sepsis

Infants diagnosed with culture-proven sepsis

No intervention

Intervention Type OTHER

This is a prospective observational cohort study. The purpose of the study was to compare the incidence of mortality, complications, and other outcomes between infants with multi-resistant bacteria sepsis and infants with sepsis caused by non-multi-resistant bacteria, and compare the incidence of complications and other outcomes between infants with sepsis-related death and infants who survive.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

This is a prospective observational cohort study. The purpose of the study was to compare the incidence of mortality, complications, and other outcomes between infants with multi-resistant bacteria sepsis and infants with sepsis caused by non-multi-resistant bacteria, and compare the incidence of complications and other outcomes between infants with sepsis-related death and infants who survive.

Intervention Type OTHER